You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas: AIDS & HIV
19 September 2023 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) announced on Wednesday that ViiV Healthcare, a global specialist HIV company primarily owned by GSK, with Pfizer and Shionogi as s...
12 September 2023 - Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, announced on Tuesday that it has partnered with the Population Council to provide its VitalDose ...
17 August 2023 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) and Tentarix Biotherapeutics have established three multi-year collaborations leveraging Tentarix's prop...
9 August 2023 - Health care solutions company Henry Schein Inc (Nasdaq: HSIC) on Wednesday unveiled its latest offering, Henry Schein Thrive Service Plus, as part of the Henry Schein Thrive Rewards pr...
8 August 2023 - Microbiome therapeutics company Seres Therapeutics (Nasdaq: MCRB) released its Q2 2023 financial results and provided key business updates on Monday.Seres announced the FDA's appr...
25 July 2023 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has posted results from multiple studies reinforcing Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/teno...
Related Headlines